/
“Innovative  Approaches to “Innovative  Approaches to

“Innovative Approaches to - PowerPoint Presentation

riley
riley . @riley
Follow
67 views
Uploaded On 2023-11-15

“Innovative Approaches to - PPT Presentation

Accessing Extracting and Aggregating Electronic Health Data Avalere Published July 17 2015 Webinar September 15 2015 Welcome Moderators Josh Rising MD Director Healthcare Programs The Pew Charitable Trusts ID: 1031908

registry data device health data registry health device medical iris research registries ehr 2015 clinical pew approaches based national

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "“Innovative Approaches to" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

1. “Innovative Approaches to Accessing, Extracting and Aggregating Electronic Health Data”Avalere • Published July 17, 2015Webinar: September 15, 2015

2. WelcomeModerators Josh Rising, MD, Director, Healthcare Programs, The Pew Charitable TrustsKristi Mitchell, MPH Senior Vice President Avalere Health, LLCAngela Franklin, JD, Senior Officer, Drugs and Medical Devices, The Pew Charitable TrustsRegistry Panelists Kathleen M. Hewitt, MSN, RN, CPHQ, Associate Vice President American College of Cardiology (ACC), National Cardiovascular Data Registry (NCDR)William L. Rich, III, MD, Medical Director of Heath Policy, American Academy of Ophthalmology (AAO), IRIS Registry

3. Webinar Agenda About Pew, AvalereStudy overviewRegistry perspectivesModerated discussion

4. Participate!Please type in your question or commentsClick “Chat” to open the chat function Questions and comments appear hereType questions here

5. The Pew Charitable TrustsPew is an independent, non-profit research and public policy organization. Pew seeks to enhance medical device safety and foster device innovation that benefits patients. Unique device identifier (UDI) Medical device registries Accelerating device innovation

6. Avalere Brings Creative Solutions to Healthcare Strategy5Avalere aims to bring innovative solutions to complex problems in an environment that demands a fresh perspective and new approaches

7. Study overviewInnovative Approaches to Accessing, Extracting and Aggregating Electronic Health DataSeptember 15, 2015

8. Innovative Approaches to Accessing, Extracting and Aggregating Electronic Health Records Data7AVALERE CONDUCTED RESEARCH ON BEHALF OF PEW TO ASSESS BARRIERS AND ENABLERS FOR MEDICAL DEVICE REGISTRIES TO EXTRACT AND AGGREGATE EHR DATAProject TaskObjectivesConceptual FrameworkConducted literature search to identify the most relevant documents to reviewCollected resident expert insight to fill any gaps in literature searchCollect Medical Device Registry DataDeveloped interview guide to structure the conversationReviewed registry-focused publicly available literatureConducted interviews with individuals from medical device registries:American College of Cardiology (ACC): National Cardiovascular Data Registry CathPCI RegistryAmerican Society for Plastic Surgeons (ASPS) and the Food and Drug Administration (FDA): National Breast Implant Registry (NBIR)American Joint Replacement Registry (AJRR)American Academy of Ophthalmology (AAO): IRIS RegistryKaiser Permanente: Total Joint Replacement Registry (TJRR)Conduct AnalysisUsed information collected to develop registry profiles that compare and contrast challenges associated with data collection, extraction and aggregationFinal ReportDeveloped a final report that:Identifies barriers and innovations for each registry as they relate to data collection, extraction and aggregationCompares these barriers and innovations across the other registries to understand similarities and differencesMakes public policy recommendations based on the findingsThe final report can be accessed here

9. Research Results: Policy Recommendations8DomainsSolutions and Policy RecommendationsLack of commonly adopted data standardsIndustry or research organizations could create a public-private sector committee to develop and implement data governance for medical device registries, including a common data model for data exchangeThe federal government (e.g. ONC, FDA) could consider developing a multi-stakeholder national registry governance body, which certifies registries based on the standards and approaches used and also participates in international registry groupsMultiple vendor proprietary platforms that lack interoperabilityThe ONC could finalize its proposed revised 2015 Edition Certification Criteria “data portability” certification criterion to incorporate the ability to send data extracts to third-party clinical data registries in its Certified EHR Technology (CEHRT) definitionThe federal government could build on recently enacted interoperability and information sharing provisions in MACRA and incentivize vendors that utilize open data standards and registries that participate in knowledge sharing networks, especially internationallyInsufficient medical device data validation practicesResearch organizations could provide policy and/or technical guidance to support routine registry data validation processes and auditsA public-private stakeholder committee could formalize processes for certifying registries that adopt and adhere to leading practices for data validation to ensure qualityNeed to incorporate UDI into the EHRFDA could lead a public-private effort to develop and implement national UDI strategyCMS and ONC could finalize Meaningful Use 3 and the 2015 Edition Certification Criteria to include incentives for UDI adoption by device manufacturers, EHR vendors and providersMaintaining patient privacy while building longitudinal recordsThe federal government, state health departments, and/or research foundations could convene groups to examine and harmonize existing privacy regulations as suggested in recent legislative proposals.Per recent legislative proposals, the federal government could amend current HIPAA privacy and security and Common Rule regulations to better support protection of patient data as data sharing increases on behalf of public health research

10. Registry perspectivesInnovative Approaches to Accessing, Extracting and Aggregating Electronic Health DataSeptember 15, 2015

11. Innovative Approaches to Accessing, Extracting and Aggregating Electronic Health DataKathleen Hewitt, MSN, RN, CPHQAssociate Vice President, NCDR

12. AgendaIntroduction to NCDRNCDR Today – Data Capture & ExchangeEnabling direct EMR integration

13. Nearly 20 years of experienceLargest outcomes-based cardiovascular patient data repository in the world Ten registries National Cardiovascular Data Registry

14. NCDR: Not Just DataBufalino VJ, Masoudi FA, et al. Circulation. 2011;123:2167-2179ClinicalResearchQualityImprovementClinical DataDatabaseQualityAssessmentMeaningful Role in Clinical Practice / U.S. Healthcare Reform Standard data elements and definitions

15. >2,500 hospitals>3,500 cardiologists>40 million clinical recordsLAAO Registry – Winter 2015/2016AF Ablation Registry – Spring 2016

16. NameDisease or DeviceFacilitySitesPatient RecordsPINNACLECoronary artery disease, heart failure, atrial fibrillation, hypertension, diabetes, peripheral arterial diseaseOutpatient44515,000,000DiabetesDiabetes andcardiometabolic care Outpatientenrolling now--CathPCIPercutaneous coronary interventionsDiagnostic catheterizationsHospital/Free Standing1,73017,000,000ICDImplantable cardioverter defibrillatorsHospital1,8151,500,000ACTION-GWTGAcute coronary syndromeSTEMI and NSTEMIHospital/EMS1030920,000PVICarotid artery revascularizationLower extremityHospital/Free Standing214340,000(CAS & CEA)IMPACTCongenital heart diseasePediatric and AdultHospital10040,000STS/ACC TVTTranscatheter Valve TherapyHospital40028,000

17. NCDR Global

18.

19. Data are collected once and used for many purposesSoftware VendorsData CapturePayorsResearchersRegulatorsAdministratorsConsumersProvidersRegistry Platform:Evidence-Based Performance MeasuresBenchmark AnalysesData Quality ProgramQI NetworkSTAKEHOLDERSDATA USES

20. Enabling direct EMR integration Overarching Goal is: Registry participation to be more about performance and outcome measurement and not about data collectionImprove time-to-market for new evidence-based data capture needsCapture data once – REALLY! Save time and $$$ Goals & Objectives

21. Say goodbye to data collectionHello “data capture”PayorsResearchersRegulatorsAdministratorsConsumersProvidersRegistry Platform:Evidence-Based Performance MeasuresQI NetworkData Quality ProgramRetrospective and Prospective Research InfrastructurePublic ReportingSTAKEHOLDERSDATA USES

22. There’s data everyone!PayorsResearchersRegulatorsAdministratorsConsumersProvidersRegistry Platform:Evidence-Based Performance MeasuresQI NetworkData Quality ProgramRetrospective and Prospective Research InfrastructurePublic ReportingSTAKEHOLDERSDATA USESHealth Info ExchangePatient Reported OutcomesRemote DevicesLabsCost

23. Patient Centered Data ModelH & PLabsMedicationsCommon In-HospitalEventsICDPCIDxCathTVTCASPVIAFibIMPACT (structural)ACS/MIPatient

24. The interconnected future of NCDR depends on standards

25. Why Standards?Standards are an agreed upon set of rulesProvide common set of definitions Help us to act and communicate with each other

26. Types of Standards3 General Buckets of Clinical Data Standards

27. Without StandardsWithout a common set of rules to define how to read digital images, this is how your vacation pictures would look

28. Journey to EHR Integration

29. EHR Integration[ project ]

30. Strategic ObjectivesHarmonize existing registry dictionaries into a single registry agnostic specification Adopt industry standard terminologies and coding systemsIncorporate within EHR certificationAdopt a single abstract transmission formatIndustry Standards

31. Expected Benefits

32. Potential Challenges

33. The grass isn’t always greenerData quality will rely on standardized clinical documentationDevelop standardsNew documentation standards for clinicians

34. Innovative Approaches to Accessing, Extracting and Aggregating Electronic Health DataKathleen Hewitt, MSN, RN, CPHQAssociate Vice President, NCDR

35. The Development of a Clinical RegistryThe IRIS Registry: Intelligent Research in Sight.

36. William L. Rich III, MD, FACSMedical Director of Health Policy American Academy of Ophthalmology

37. Introduction to the IRIS™ RegistryIRIS™ Registry (Intelligent Research In Sight), the nation’s first comprehensive eye disease clinical registry:Enables ophthalmologists across the country to use clinical data to improve care delivery and patient outcomes. Uses scientifically valid and HIPAA-compliant methods to collect data from patient records – directly from electronic health record systems using a systems integrator. Helps ophthalmology practices meet the requirements of the federal Physician Quality Reporting System, measure resource use and outcomes of interventions-surgery, biologics and devices

38. PrinciplesOphthalmologists own their data.Ophthalmologists give permission for data to be distributed and reported.Academy owns aggregated data.Data protection/security/quality and audits in place.

39. Keys to Successful Clinical Registry DevelopmentPhysician engagement in the measure development and designRobust value propositionNo impact on workflow

40. Enhancing engagementMeasures must be inclusive of as many members and patients as possible ( from pediatrics to Medicare, chronic/acute conditions to interventions). Value proposition must be broad based-private practice, academic groups, multispecialty groups, solo practitionersData dictionary with 900+ data pointsRobust measures result in key data elements in the registry not present in the EHR

41. IRIS ChronologyNovember 2011-registry task force formedFebruary 2012-development plan presented to BoardNovember 2012- Board approves fundingDecember 2012-December 2013-measures selected and tested, communication strategy delineated, data dictionary established

42. Launch March 2014Goal: 2200 ophthalmologists by 2017 with 18 million patients

43. IRIS Status August 201532 different EHR systems integrated2 Epic Academic Medical Centers with signed contracts and active discussions on integration80% of ophthalmologist on EHR participating in IRIS

44. September 1, 2015

45. IRIS 2015 ProjectionIn 2015 - doubling of integrated docs on EHR to 6,000 and total of 8,000 utilizing IRIS for quality reportingNew goal? 8,000 docs and 48 million patients by 2017 If we reach this new goal in 2017 the number of patient visits that year will approach 152 million.

46. Value PropositionFinancialMOC-Part IVBetter outcomesResearchInforming public policyPopulation HealthSurveillance

47. Improved Outcomes

48. Lundstrom M, et al. Decreasing rate of capsule complications in cataract surgery : Eight-year study of incidence, risk factors, and data validity by the Swedish National Cataract RegisterJCRS, Volume 37, Issue 10, 2011, 1762 - 1767 602,553 cataract surgeriesMultivariate analysis: age, poor preop visual acuity, glaucoma diagnosis, lower volume hospitals.Overtime, all decreased.

49. EUREQUO project: European Registry of Quality Outcomes for Cataract and Refractive Surgery368,258 cataract surgeriesVariable20/40 or Better 20/20 No. of ptswithout ocular comorbidity98.2 %69.9 %274,155with ocular comorbidity82.635.994,103Comorbidity Macular degeneration80.730.235,029 Glaucoma89.747.221,088 Diabetic retinopathy83.737.811,299 Amblyopia58.716.16,650 Other81.134.827,214

50. Research

51. Randomized Registry TrialThe Randomized Registry Trial-The Next Disruptive Technology in Clinical Research --Lauer & D’Agostino, NEJM, Sept 2013 Time for recruitment and costs were dramatically less in the randomized registry arm of the trial.The incremental cost of the Thrombus Aspiration in ST-Elevation Myocardial Infarction in Scandinavia (TASTE) trial was $300,000, or $50 for each participant who underwent randomization!

52. Inform Public PolicyAvastin Compounding

53. Endophthalmitis RateDrugInjections%Avastin478,3810.12%Lucentis245,3810.09%Eylea103,3900.12%

54. Population Health

55. Improved Population Health

56. Population HealthCDC Vision Health Surveillance ProjectPCORI- CER proposalCMS Transformation NetworkNEI Infectious Disease Proposal

57. SurveillanceDevices and Drugs

58. PEW: Future Directions for Medical Device Registries60% of Class III devices have mandated post market surveillance and only 6% are performed by independent specialty registries.UDIs ( Unique Device Identifiers) will be included in EHRs in 2015?Longitudinal EHR based registries ( Pinnacle, IRIS) have the capability to follow devices at the longitudinal point of care and can detect early signals. Patient reported outcome tools can pick up early symptoms before device failure occurs.Data should be made publicly available

59. IRIS and UDIsIf CDC mandates UDIs in certified EHR fields in the next year, IRIS can extract themCurrently IRIS collects device data inputted into a surgical template that is uploaded to the registryThe majority of devices are inserted in ASCs without EHRs

60. Overcoming Hurdles Inadequate data points in EHRs-*Validation of data-*Data blocking: vendor fees & refusal to allow export of data-ongoing battle with two large vendorsImporting UDI

61. Moderated discussionInnovative Approaches to Accessing, Extracting and Aggregating Electronic Health DataSeptember 15, 2015

62. Participate!Please type in your question or commentsClick “Chat” to open the chat function Questions and comments appear hereType questions here

63. Discussion with Panelists Kathleen M. Hewitt, MSN, RN, CPHQ, Associate Vice President American College of Cardiology (ACC), National Cardiovascular Data Registry (NCDR)William L. Rich, III, MD, Medical Director of Health Policy, American Academy of Ophthalmology (AAO), IRIS RegistryModerators:Josh Rising, MD, Director, Healthcare Programs, The Pew Charitable TrustsKristi Mitchell, MPH Senior Vice President Avalere Health, LLCParticipate!Please type in your question or comments

64. Stay Informed! Available at avalere.com

65. Thank you!Josh Rising, MD, Director, Healthcare Programs, The Pew Charitable TrustsAngela Franklin, JD, Senior Officer, Drugs and Medical Devices The Pew Charitable TrustsKristi Mitchell, MPH Senior Vice President Avalere Health, LLC